LLY

911.65

+0.96%↑

JNJ

235.8

+0.14%↑

ABBV

205.01

+0.38%↑

NVS

147.58

+1.16%↑

AZN

184.25

+0.48%↑

LLY

911.65

+0.96%↑

JNJ

235.8

+0.14%↑

ABBV

205.01

+0.38%↑

NVS

147.58

+1.16%↑

AZN

184.25

+0.48%↑

LLY

911.65

+0.96%↑

JNJ

235.8

+0.14%↑

ABBV

205.01

+0.38%↑

NVS

147.58

+1.16%↑

AZN

184.25

+0.48%↑

LLY

911.65

+0.96%↑

JNJ

235.8

+0.14%↑

ABBV

205.01

+0.38%↑

NVS

147.58

+1.16%↑

AZN

184.25

+0.48%↑

LLY

911.65

+0.96%↑

JNJ

235.8

+0.14%↑

ABBV

205.01

+0.38%↑

NVS

147.58

+1.16%↑

AZN

184.25

+0.48%↑

Search

ResMed Inc

Closed

SectorHealthcare

228.13 1.1

Overview

Share price change

24h

Current

Min

225.64

Max

230.98

Key metrics

By Trading Economics

Income

44M

393M

Sales

87M

1.4B

P/E

Sector Avg

22.833

57.833

Dividend yield

0.98

Profit margin

27.593

Employees

10,600

EBITDA

63M

566M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+31.07% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.98%

2.47%

Next Earnings

22 Apr 2026

Next Dividend date

11 Jun 2026

Next Ex Dividend date

7 May 2026

Market Stats

By TradingEconomics

Market Cap

-3.6B

34B

Previous open

227.03

Previous close

228.13

News Sentiment

By Acuity

18%

82%

28 / 350 Healthcare

ResMed Inc Chart

Past performance is not a reliable indicator of future results.

Related News

22 Mar 2026, 23:50 UTC

Market Talk

Global Equities Roundup: Market Talk

22 Mar 2026, 23:50 UTC

Market Talk

LG Electronics Set to Stage Strong Earnings Rebound in 1Q -- Market Talk

22 Mar 2026, 23:49 UTC

Market Talk
Major News Events

Gold Edges Lower on Prospects of Liquidity-Driven Sales -- Market Talk

22 Mar 2026, 23:49 UTC

Market Talk
Major News Events

Nikkei May Fall as Concerns About Middle East Conflict Persist -- Market Talk

22 Mar 2026, 23:49 UTC

Market Talk
Major News Events

Global Forex and Fixed Income Roundup: Market Talk

22 Mar 2026, 23:41 UTC

Market Talk
Major News Events

Oil Edges Lower as Traders Eye Trump's Deadline to Reopen Strait of Hormuz -- Market Talk

22 Mar 2026, 22:57 UTC

Acquisitions, Mergers, Takeovers

Perseus Mining: Location of Aurum's Discoveries Present Potential Future Synergies

22 Mar 2026, 22:56 UTC

Acquisitions, Mergers, Takeovers

Perseus Mining: Aurum Share Acquisition Cost A$23.69 Million

22 Mar 2026, 22:56 UTC

Acquisitions, Mergers, Takeovers

Perseus Mining: Aurum's Boundiali Gold Project Located to South of Sissingue Gold Mine

22 Mar 2026, 22:55 UTC

Acquisitions, Mergers, Takeovers

Perseus Mining: Participated in Aurum Resources Equity Raising

22 Mar 2026, 22:54 UTC

Acquisitions, Mergers, Takeovers

Perseus Mining: Acquires 9.9% Interest in Aurum Resources

22 Mar 2026, 22:22 UTC

Market Talk
Major News Events

After Selloff, Gold Seen Supported by Strait of Hormuz Deadline -- Market Talk

22 Mar 2026, 22:06 UTC

Acquisitions, Mergers, Takeovers

Synopsys Has Market Value Over $80 Billion; Major Customers Include Nvidia -- WSJ

22 Mar 2026, 22:06 UTC

Acquisitions, Mergers, Takeovers

Activist Elliott Builds Big Stake in Chip-Design Software Maker Synopsys -- WSJ

22 Mar 2026, 22:06 UTC

Acquisitions, Mergers, Takeovers

Activist Elliott Investment Management Has Multibillion-Dollar Investment in Synopsys, Sources Say -- WSJ

22 Mar 2026, 22:06 UTC

Acquisitions, Mergers, Takeovers

Elliott Plans to Push Synopsys to Make More Money From Its Software and Services, Sources Say -- WSJ

22 Mar 2026, 21:53 UTC

Earnings

Zijin Gold International Plans 59.2 Tons of Gold Production in 2026; up 12.3% on Year >2259.HK

22 Mar 2026, 21:53 UTC

Earnings

Zijin Gold International Rising Gold Prices Supported Results >2259.HK

22 Mar 2026, 21:53 UTC

Earnings

Zijin Gold International 2025 Rev $5.38B Vs. $2.99B >2259.HK

22 Mar 2026, 21:53 UTC

Earnings

Zijin Gold International 2025 Net $1.60B Vs. Net $481.37M >2259.HK

22 Mar 2026, 21:31 UTC

Earnings

China Petroleum & Chemical Plans CNY131.6B-CNY148.6B Capex Spending in 2026>0386.HK

22 Mar 2026, 21:31 UTC

Earnings

China Petroleum & Chemical: Decrease in Sales Volumes of Refined Oil Products Also Hurt Results >0386.HK

22 Mar 2026, 21:31 UTC

Earnings

China Petroleum & Chemical 2025 Results Weighed by Decrease in Prices of Petroleum, Petrochemical Products>0386.HK

22 Mar 2026, 21:31 UTC

Earnings

China Petroleum & Chemical 2025 Rev CNY2.78T Vs. CNY3.07T >0386.HK

22 Mar 2026, 21:31 UTC

Earnings

China Petroleum & Chemical 2025 Net CNY32.48B Vs. Net CNY48.94B >0386.HK

22 Mar 2026, 21:25 UTC

Market Talk
Major News Events

Bonds Decoupling From Oil Amid Longer Conflict Fears -- Market Talk

22 Mar 2026, 21:22 UTC

Acquisitions, Mergers, Takeovers

St Barbara: Remarks Follow Recent Inquiries About Simberi's Fuel Stocks

22 Mar 2026, 21:21 UTC

Acquisitions, Mergers, Takeovers

St Barbara: Simberi Currently Uses About 65,000 Liters Per Day For Mining Fleet, Power Generation

22 Mar 2026, 21:21 UTC

Market Talk

Revised Fuel Subsidy Mechanism Positive for Ampol, Viva Energy -- Market Talk

22 Mar 2026, 21:21 UTC

Acquisitions, Mergers, Takeovers

St Barbara: Has Been Taking Precaution to Increase Diesel Storage For Several Months

Peer Comparison

Price change

ResMed Inc Forecast

Price Target

By TipRanks

31.07% upside

12 Months Forecast

Average 296.2 USD  31.07%

High 345 USD

Low 265 USD

Based on 12 Wall Street analysts offering 12 month price targets forResMed Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

12 ratings

7

Buy

5

Hold

0

Sell

Sentiment

By Acuity

28 / 350 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat